Benchmarking free energy calculations: Analysis of single and double mutations across two simulation software platforms for two protein systems
Benchmarking von Free-Energy-Berechnungen: Analyse von Einzel- und Doppeltmutationen über zwei Simulationssoftware-Plattformen für zwei Proteinsysteme
PLOS One · 03.04.2026 · 21 (4) · e0335829
DOI: 10.1371/journal.pone.0335829 ↗Auf einen Blick
Verglichen wurden FEP-Simulationen für Mutationen in S. nuclease und T4 Lysozyme mit Schrödinger und GROMACS. Beide Plattformen zeigten starke Korrelationen mit experimentellen ΔΔG-Werten.
Fragestellung
Wie gut stimmen FEP-Berechnungen für Einzel- und Doppeltmutationen in S. nuclease und T4 Lysozyme zwischen Schrödinger und GROMACS sowie mit experimentellen Daten überein?
Methode
Vergleichende Computationsanalyse von FEP-Simulationen für Mutationen in S. nuclease und T4 Lysozyme mit Schrödinger und GROMACS; OPLS4 bzw. Amber99SB-ILDN.
Ergebnisse
Bei 38 Einzelmutanten von S. nuclease betrug r 0,86 mit Schrödinger und 0,87 mit GROMACS. Bei 24 Einzelmutanten von T4 Lysozyme lag r bei 0,80 bzw. 0,85. Für 45 Doppeltmutationen in S. nuclease betrug r 0,74 zu Experimenten und 0,71 zu GROMACS.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass Schrödinger FEP+ und GROMACS effizient, genau und zuverlässig zur Vorhersage mutationsbedingter freier Energieänderungen sind.
Kernaussagen
- S. nuclease: 38 Einzelmutanten, r 0,86 bzw. 0,87
- T4 Lysozyme: 24 Einzelmutanten, r 0,80 bzw. 0,85
- 45 Doppeltmutationen: gute Übereinstimmung der berechneten ΔΔG-Werte
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.04.2026. Verfasst von Shivani Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Temple University, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Software, Muramidase, Mutation, Molecular Dynamics Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Mutation analysis of single and double mutations of proteins including the two widely studied proteins: Staphylococcus nuclease (S. nuclease) and T4 lysozyme, provides critical insights into their stability and fitness. Furthermore, such analysis facilitates a deeper understanding of the complex interplay between a protein's sequence, structural conformation, and functional output. Free Energy Perturbation (FEP) is an alchemical, all-atom molecular dynamics based computational approach that determines the free energy change ( Δ Δ G ) from wild type to mutant states. Two widely adopted software platforms used for this purpose are Schrödinger and GROMACS. We have compared the results of FEP simulations for mutations using these platforms, employing the OPLS4 force field implemented in Schrödinger, and the Amber99SB-ILDN force field implemented in GROMACS for this work. For the 38 single mutants of S. nuclease, the Pearson r between the experimental and the calculated free energy change ( Δ Δ G ) was 0.86 using Schrödinger and 0.87 using GROMACS. The reliability of the FEP method using the two software platforms with the specified force fields was further demonstrated by its performance on 24 single mutants of T4 lysozyme, yielding strong correlation between predicted and experimental Δ Δ G values, with Pearson r of 0.80 for Schrödinger and 0.85 for GROMACS. Additionally, the computed folding free energy changes for 45 double mutations in S. nuclease ( Δ Δ G W T A B ) using Schrödinger correlated well with both experimental measurements (Pearson r = 0.74) and previously reported GROMACS values (Pearson r = 0.71). Correspondingly, the nonadditivities ( δ W T A B ) of the double mutations derived using Schrödinger for these 45 double mutants of S. nuclease were also found to be in good agreement with the experimental values (Pearson r = 0.79), as well as with the previously reported GROMACS results (Pearson r = 0.61). A good correlation was also observed between computed values from Schrödinger and GROMACS, with a Pearson r of 0.71 for double mutants and 0.61 for their nonadditivities. Collectively, these findings establish the efficiency, accuracy, and reliability of Schrödinger FEP+ and GROMACS in predicting mutation-induced free energy changes in S. nuclease and T4 lysozyme. The integration of FEP based computational methodologies with experimental validation provides a framework for quantifying mutation-induced changes in protein thermostability, which can be used as a tool for protein engineering and design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Temple University, Philadelphia, Pennsylvania, United States of America.
- Center for Biophysics and Computational Biology, Temple University, Philadelphia, Pennsylvania, United States of America.
ORCID-Profile: Shivani Gupta, Ronald M Levy
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Gupta, S., Sun, Q., & Levy, R. M. (2026). Benchmarking free energy calculations: Analysis of single and double mutations across two simulation software platforms for two protein systems. PLOS One, 21(4), e0335829. https://doi.org/10.1371/journal.pone.0335829
Vancouver
Gupta S, Sun Q, Levy RM. Benchmarking free energy calculations: Analysis of single and double mutations across two simulation software platforms for two protein systems. PLOS One. 2026;21(4):e0335829. doi:10.1371/journal.pone.0335829
BibTeX
@article{Gupta2026,
author = {Gupta, Shivani and Sun, Qinfang and Levy, Ronald M},
title = {Benchmarking free energy calculations: Analysis of single and double mutations across two simulation software platforms for two protein systems},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0335829},
doi = {10.1371/journal.pone.0335829}
}
EUVIMED